JMP Securities Downgrades Proteon Therapeutics (PRTO) to Market Perform Mar 28, 2019 10:58AM
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results Mar 13, 2019 08:00AM
Pre-Open Stock Movers 02/11: (NUVA) (CAR) (EA) Higher; (RGSE) (BBBY) (GT) Lower (more...) Feb 11, 2019 09:29AM
JMP Securities Upgrades Proteon Therapeutics (PRTO) to Market Outperform Feb 11, 2019 01:57AM
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st Jun 14, 2018 08:00AM


May 9, 2018 08:10AM Proteon Therapeutics Announces First Quarter 2018 Financial Results
Jun 15, 2017 08:00AM Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
May 10, 2017 08:00AM Proteon Therapeutics Announces First Quarter 2017 Financial Results
Mar 16, 2017 07:15AM Proteon Therapeutics Announces Full-Year 2016 Financial Results and Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial
Jun 15, 2016 08:00AM Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd
May 9, 2016 08:00AM Proteon Therapeutics Announces First Quarter 2016 Financial Results
Jun 17, 2015 08:00AM Proteon Therapeutics to Present at the JMP Securities Life Science Conference June 24th
Nov 24, 2014 08:00AM Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares
Nov 17, 2014 08:03AM JMP Securities Starts Proteon Therapeutics (PRTO) at Market Outperform
Oct 22, 2014 10:50AM Proteon Therapeutics (PRTO) IPO Opens Higher
Oct 22, 2014 09:01AM Proteon Therapeutics (PRTO) IPO Prices at $10, Below Expected Range